Skip to main content
Premium Trial:

Request an Annual Quote

LightArray to Provide Aushon BioSystems' Products and Services in China

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Aushon BioSystems today said that LightArray Biotech will provide the firm's multiplex biomarker products and services in China.

LightArray operates a drug development services lab in Wuxi, China. Aushon said that the firm will offer its biomarker technologies, including more than 300 validated assays, multiplex biomarker sample testing services and kits, custom arrays and assay development, and array imaging and analysis systems.

LightArray will offer the products and services to pharmaceutical, biotech, and academic institutions located in mainland China.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.